Cannabis Clinic for People With Early Psychosis
Part of Mental health clinical trials.
This trial tests a specialized cannabis clinic designed to help people cut back or stop using cannabis if they've had a first episode of psychosis. The goal is to see if the clinic helps reduce cannabis use and improve mental health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a first episode of psychosis and are under an Early Intervention team (like SLaM in South London).
- You use cannabis at least a few times a week and it's causing problems in your life (like trouble with work or relationships).
- You are between 18 and 65 years old.
- You are not currently in crisis or having suicidal thoughts.
- You do not use other illegal drugs (like cocaine or heroin) more than once a week.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a short, one-time program designed to help people ages 18-25 who use cannabis frequently (at least 20 days per month) reduce their use. It may be a good fit if you're not already in treatment and are thinking about making a change.
This study tests a computer-based cognitive training program to help people with early psychosis reduce their alcohol and cannabis use. The program is designed to improve thinking skills and may make it easier to cut back on substance use.
This study tests if psilocybin (a substance that can change how you think and feel) can help people reduce or stop using cannabis. You will receive support and be monitored closely throughout the trial.
This study uses brain imaging to understand how thinking works in people who use cannabis, comparing those with psychosis to people without psychosis. It may help researchers learn what brain patterns relate to thinking difficulties and how cannabis use fits in.
This study tests if adding a CBD medication to your current antipsychotic can improve symptoms in people with schizophrenia or related disorders who started treatment recently but aren't fully better yet.
This trial tests whether adding cannabidiol (CBD) to clozapine improves symptoms in people with early psychosis. It is for those who have been on clozapine for at least 8 weeks and still have some symptoms.
Hear when a new Psychosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.